Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K6UK
|
|||
Former ID |
DNC001265
|
|||
Drug Name |
Saframycin A
|
|||
Synonyms |
AC1MHXXG
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C29H30N4O8
|
|||
Canonical SMILES |
CC1=C(C(=O)C2=C(C1=O)CC3C4C5=C(CC(N4C)C(N3C2CNC(=O)C(=O)C)C#N)C(=O)C(=C(C5=O)OC)C)OC
|
|||
InChI |
1S/C29H30N4O8/c1-11-23(35)14-8-17-22-21-15(24(36)12(2)28(41-6)26(21)38)7-16(32(22)4)18(9-30)33(17)19(10-31-29(39)13(3)34)20(14)25(37)27(11)40-5/h16-19,22H,7-8,10H2,1-6H3,(H,31,39)/t16-,17-,18-,19-,22-/m0/s1
|
|||
InChIKey |
JNEGMBHBUAJRSX-SHUHUVMISA-N
|
|||
CAS Number |
CAS 66082-27-7
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) | Target Info | Binder | [1] |
BioCyc | Superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle | |||
Gluconeogenesis | ||||
NADH repair | ||||
Glycolysis | ||||
KEGG Pathway | Glycolysis / Gluconeogenesis | |||
Metabolic pathways | ||||
Biosynthesis of antibiotics | ||||
Carbon metabolism | ||||
Biosynthesis of amino acids | ||||
HIF-1 signaling pathway | ||||
Alzheimer's disease | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
TSH Signaling Pathway | ||||
Panther Pathway | Glycolysis | |||
Huntington disease | ||||
Pathwhiz Pathway | Glycerol Phosphate Shuttle | |||
Glycolysis | ||||
Gluconeogenesis | ||||
Mitochondrial Electron Transport Chain | ||||
Warburg Effect | ||||
Pathway Interaction Database | Validated targets of C-MYC transcriptional activation | |||
Reactome | Glycolysis | |||
Gluconeogenesis | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Glycolysis and Gluconeogenesis | ||||
Alzheimers Disease | ||||
Cori Cycle |
References | Top | |||
---|---|---|---|---|
REF 1 | Identification of GAPDH as a protein target of the saframycin antiproliferative agents. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5862-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.